297 related articles for article (PubMed ID: 31387735)
21. Prognostic analysis for treatment modalities in hepatocellular carcinomas with portal vein tumor thrombi.
Zhou Q; Wang Y; Zhou X; Peng B; Yang J; Liang L; Li J
Asian Pac J Cancer Prev; 2011; 12(11):2847-50. PubMed ID: 22393952
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
Pan T; Li XS; Xie QK; Wang JP; Li W; Wu PH; Zhao M
Clin Radiol; 2014 Dec; 69(12):e553-61. PubMed ID: 25304928
[TBL] [Abstract][Full Text] [Related]
23. Sorafenib
Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
Anticancer Res; 2020 Apr; 40(4):2283-2290. PubMed ID: 32234927
[TBL] [Abstract][Full Text] [Related]
24. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus.
Minagawa M; Makuuchi M; Takayama T; Ohtomo K
Ann Surg; 2001 Mar; 233(3):379-84. PubMed ID: 11224626
[TBL] [Abstract][Full Text] [Related]
25. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T
Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678
[TBL] [Abstract][Full Text] [Related]
26. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.
Zhang YF; Wei W; Guo ZX; Wang JH; Shi M; Guo RP
Jpn J Clin Oncol; 2015 Sep; 45(9):837-43. PubMed ID: 26079139
[TBL] [Abstract][Full Text] [Related]
27. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
28. Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis.
Carr BI; Irish W; Federle MP
Hepatogastroenterology; 2010; 57(104):1375-81. PubMed ID: 21443089
[TBL] [Abstract][Full Text] [Related]
29. Complete pathological response induced by sorafenib for advanced hepatocellular carcinoma with multiple lung metastases and venous tumor thrombosis allowing for curative resection.
Kitajima T; Hatano E; Mitsunori Y; Taura K; Fujimoto Y; Mizumoto M; Okajima H; Kaido T; Minamiguchi S; Uemoto S
Clin J Gastroenterol; 2015 Oct; 8(5):300-5. PubMed ID: 26249525
[TBL] [Abstract][Full Text] [Related]
30. Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus.
Yu TZ; Zhang W; Liu QX; Li WH; Ma JQ; Zhang ZH; Yang MJ; Wang JH; Chen B; Zeng SC; Luo JJ; Liu LX; Yan ZP
Oncotarget; 2017 Feb; 8(7):12108-12119. PubMed ID: 28076848
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein.
Yamakado K; Tanaka N; Nakatsuka A; Matsumura K; Takase K; Takeda K
J Hepatol; 1999 Apr; 30(4):660-8. PubMed ID: 10207808
[TBL] [Abstract][Full Text] [Related]
32. New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.
Woo HY; Heo J
Clin Mol Hepatol; 2015 Jun; 21(2):115-21. PubMed ID: 26157747
[TBL] [Abstract][Full Text] [Related]
33. [A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization].
Yamamoto T; Nagano H; Sakon M; Miyamoto A; Kondo M; Arai I; Morimoto O; Dono K; Umeshita K; Nakamori S; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1718-23. PubMed ID: 11708017
[TBL] [Abstract][Full Text] [Related]
34. New Systemic Treatments in Advanced Hepatocellular Carcinoma.
Sanduzzi-Zamparelli M; Díaz-Gonzalez Á; Reig M
Liver Transpl; 2019 Feb; 25(2):311-322. PubMed ID: 30317696
[TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolization in a patient with recurrent hepatocellular carcinoma and portal vein thrombosis: a case report and review of the literature.
Sikander A; Sadashiv S; Ronald S; Milind J
Am J Clin Oncol; 2005 Dec; 28(6):638-9. PubMed ID: 16317281
[TBL] [Abstract][Full Text] [Related]
36. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy.
Kim PH; Choi SH; Kim JH; Park SH
Korean J Radiol; 2019 Mar; 20(3):385-398. PubMed ID: 30799569
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
Liu PH; Huo TI; Miksad RA
Semin Liver Dis; 2018 Aug; 38(3):242-251. PubMed ID: 30041276
[TBL] [Abstract][Full Text] [Related]
39. Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply.
Yim HJ; Ahn YE; Kim TH; Jung YK
Gut Liver; 2023 Mar; 17(2):341-342. PubMed ID: 36789579
[No Abstract] [Full Text] [Related]
40. [Comparative study of portal vein stent and TACE combined therapy with or without endovascular implantation of iodine-125 seeds strand for treating patients with hepatocellular carcinoma and main portal vein tumor thrombus].
Wu LL; Luo JJ; Yan ZP; Wang JH; Wang XL; Zhang XB; Fang ZT; Zhang W
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):915-9. PubMed ID: 23522253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
